Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
ClavystBio launches to translate life sciences breakthroughs into health impact 2022-09-15 10:00
Juniper Biologics Establishes Global Headquarters in Singapore 2022-09-15 09:53
Gracell Biotechnologies to Participate in Three Upcoming Investor Conferences 2022-09-14 20:30
DR CATHERINE MOHR TO JOIN BOARD OF MEDTECH COMPANY AROA BIOSURGERY 2022-09-14 13:05
MD ANDERSON AND RADIOPHARM THERANOSTICS LAUNCH JOINT VENTURE TO DEVELOP NOVEL RADIOPHARMACEUTICALS 2022-09-14 11:09
Data from KN046 in Patients with metastatic NSCLC who failed first line treatment or prior EGFR-TKIs Presented at ESMO 2022 2022-09-14 09:11
GBB Lands USD 15M Pre-Series B Funding Led by Tiger Jade Capital 2022-09-14 09:08
Alphamab Oncology Presents the updated data from Phase 2 Clinical trial on KN046 Combined with platinum doublet chemotherapy as first-line(1L)treatment for NSCLC at ESMO 2022 2022-09-14 09:04
Updated Data Presented for KN026 comboKN046 in 1st Line HER2-Positive Gastric/Gastroesophageal Junction Cancer (GC/GEJ) 2022-09-14 09:01
Antengene Unveils Its First Australian Office to Continue Expanding Global Presence 2022-09-14 08:30
Debiopharm Co-leads a 10M USD Series A Round to Accelerate the Development of Genomic Medicines through Artificial Intelligence 2022-09-14 00:48
TRANSFORM 1 Enrollment Completed: A Crucial RCT ready to redefine the DCB Angioplasty Mechanism 2022-09-13 22:15
AnBogen Therapeutics Receives Approval from U.S. FDA for Phase Ib/II Protocol Amendment for ABT-101 2022-09-13 22:00
EDGC (Eone Diagnomics Genome Center) recruits Sam Martin, Vice President of Overseas Business Development... to "accelerate entering the overseas market" 2022-09-13 21:00
Turn Biotechnologies launches eTurna™ delivery platform designed specifically to enable nucleic acid therapeutics 2022-09-13 20:38
I-Mab Announces Approval from China CDE to Initiate Phase 3 Registrational Study of Lemzoparlimab in Combination with Azacitidine in Higher-Risk Myelodysplastic Syndrome 2022-09-13 20:00
AO Foundation acquires RIMASYS to advance the surgical education ecosystem of the future 2022-09-13 18:00
TikoMed's ILB(R) inhibits cell infection by coronaviruses and modulates reactive cytokine release from microglia in vitro 2022-09-13 16:08
Transcenta Releases Encouraging Interim Safety and Efficacy Data of the TST001 (Osemitamab) and Chemotherapy Combination Expansion Cohort for First Line Claudin18.2 Positive Gastric Cancer at ESMO Congress 2022 2022-09-13 08:00
Aldatu Biosciences Adds Another Outbreak Disease to Pandemic Preparedness Portfolio 2022-09-13 00:33
1 154 155 156 157 158 453